Nyxoah Raises EUR15 Million in New Financing, Completes BLAST ...
MONT-SAINT-GUIBERT, Belgium, November 12, 2018 /PRNewswire-AsiaNet/ -- Nyxoah S.A., a medical device company focused on the development and commercialization of a best-in-class hypoglossal nerve stimulation (HGNS) therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it successfully ra...
Read more https://view-release/?pr-id=76207